SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,520.87 233.75
(0.47%)

Dow Jones

6,986.78 44.32
(0.64%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.93 -0.23
(-0.25%)

EUR-INR

105.10 -0.46
(-0.44%)

GBP-INR

121.29 -0.65
(-0.53%)

JPY-INR

0.57 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

88.81

415072.95

EPS(TTM)

Face Value()

Div & Yield %

19.48

0.92

Back

Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter

Nov 05,2025

Net profit of Sun Pharmaceutical Industries rose 2.56% to Rs 3117.95 crore in the quarter ended September 2025 as against Rs 3040.16 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 14405.22 crore in the quarter ended September 2025 as against Rs 13264.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	14405.22	13264.22	9
OPM %	31.43	29.70	-
PBDT	4897.11	4223.79	16
PBT	4167.61	3597.88	16
NP	3117.95	3040.16	3

83,576.24 -604.72 ( -0.72%)

49,520.87 233.75 (0.47%)

6,986.78 44.32 (0.64%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.93 -0.23 (-0.25%)

105.10 -0.46 (-0.44%)

121.29 -0.65 (-0.53%)

0.57 0.00 (-0.31%)